FAQ
Log In
Thursday 2nd April 2015
News
 › 
 › 

GSK's HIV drug matches Merck

2nd April 2012

A new once-daily HIV drug developed by GSK is as good as Merck's twice-daily rival.


Click on available sources in right hand menu to see the original article.

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: GSK's HIV drug matches Merck
Author: Martine Hamilton
Article Id: 21563
Date Added: 2nd Apr 2012

Sources

Yahoo News

Recent Related Articles

Unlicensed cancer drug fast-tracked to NHS patients

Hunt for effective weight loss drugs

malaria2

Drug-resistant malaria a huge threat

New Ebola drug trial begins

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2015